Zhu Chunxiao, Wei Baozhen, Li Yang, Wang Changyuan
School of Clinical Medicine, Shandong Second Medical University, Weifang, China.
Department of Dermatology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, China.
Front Microbiol. 2025 Jun 4;16:1565111. doi: 10.3389/fmicb.2025.1565111. eCollection 2025.
() is closely related to the pathogenesis of acne, and studies related to the antibiotic resistance rates of have been reported worldwide; however, relevant systematic reviews and meta-analyses are still lacking. The aim of this study was to systematically evaluate the resistance in to relevant antibiotics, that this information may be used to provide a rational basis for the antibiotic treatment of acne.
Relevant studies in PubMed, the Cochrane Library, EMBASE, Web of Science, China National Knowledge Infrastructure (CNKI) and Wanfang Data were systematically searched from January 1, 2005, to April 1, 2025, and the resistance rates of isolates to quinolones, macrolides, tetracyclines, and other relevant antibiotics were collected. The combined resistance rate was calculated via the language program package 4.3.2, with subgroup analyses based on different years, continents, countries, provinces in China and different drug susceptibility testing methods.
A total of 8,846 studies were systematically retrieved and 23 studies were included, corresponding to 2,046 isolates of , which have shown antibiotic resistance rates ranging from high to low: 48.17% (95% CI: 41.16-55.24%) for roxithromycin, 45.64% (95% CI: 20.49-73.22%) for clarithromycin, 43.33% (95% CI: 27.81-60.29%) for azithromycin, 29.20% (95% CI: 22.14-37.43%) for erythromycin, 22.38% (95% CI: 14.69-32.56%) for clindamycin, 5.93% (95% CI: 2.91-11.69%) for levofloxacin, 2.44% (95% CI: 0.99-5.89%) for doxycycline, 1.47% (95% CI: 0.00-85.72%) for trimethoprim-sulfamethoxazole (TMP-SMX), 1.31% (95% CI: 0.45-3.70%) for tetracycline, 0.28% (95% CI: 0.04-1.94%) for chloramphenicol, 0.22% (95% CI: 0.03-1.89%) for minocycline. Subgroup analysis revealed that, compared with those in other regions, the resistance rates to macrolides and clindamycin were higher in China. In addition, the levofloxacin, erythromycin, and clindamycin resistance rates were progressively increasing over time.
In certain regions, the relatively high antibiotic resistance rates (e.g., 77% (95% CI: 62-87%) for clarithromycin in China) in isolates may be attributed to the overuse of antibiotics in acne treatment. The resistance rates in to tetracyclines, such as 2.44% (95% CI: 0.99-5.89%) for doxycycline, remain relatively low, which allows tetracyclines to continue serving as first-line antibiotics for acne treatment. In addition, the resistance rates to levofloxacin, erythromycin, and clindamycin markedly increased over time ( < 0.05). This emphasizes the significance of rational use of the antibiotics in acne treatment.
()与痤疮的发病机制密切相关,全球已报道了有关()抗生素耐药率的研究;然而,相关的系统评价和荟萃分析仍然缺乏。本研究的目的是系统评价()对相关抗生素的耐药性,以便为痤疮的抗生素治疗提供合理依据。
系统检索了2005年1月1日至2025年4月1日期间PubMed、Cochrane图书馆、EMBASE、Web of Science、中国知网(CNKI)和万方数据中的相关研究,收集了()分离株对喹诺酮类、大环内酯类、四环素类及其他相关抗生素的耐药率。通过RevMan语言程序包4.3.2计算合并耐药率,并根据不同年份、大洲、国家、中国省份及不同药敏试验方法进行亚组分析。
共系统检索到8846项研究,纳入23项研究,对应2046株(),其抗生素耐药率从高到低依次为:罗红霉素48.17%(95%CI:41.16 - 55.24%)、克拉霉素45.64%(95%CI:20.49 - 73.22%)、阿奇霉素43.33%(95%CI:27.81 - 60.29%)、红霉素29.20%(95%CI:22.14 - 37.43%)、克林霉素22.38%(95%CI:14.69 - 32.56%)、左氧氟沙星5.93%(95%CI:2.91 - 11.69%)、多西环素2.44%(95%CI:0.99 - 5.89%)、复方磺胺甲恶唑(TMP - SMX)1.47%(95%CI:0.00 - 85.72%)、四环素1.31%(95%CI:0.45 - 3.70%)、氯霉素0.28%(95%CI:0.04 - 1.94%)、米诺环素0.22%(95%CI:0.03 - 1.89%)。亚组分析显示,与其他地区相比,中国对大环内酯类和克林霉素的耐药率更高。此外,左氧氟沙星、红霉素和克林霉素的耐药率随时间逐渐升高。
在某些地区,()分离株相对较高的抗生素耐药率(如中国克拉霉素耐药率为77%(95%CI:62 - 87%))可能归因于痤疮治疗中抗生素的过度使用。()对四环素类的耐药率仍然相对较低,如多西环素为2.44%(95%CI:0.99 - 5.89%),这使得四环素类仍可作为痤疮治疗的一线抗生素。此外,左氧氟沙星、红霉素和克林霉素的耐药率随时间显著升高(P<0.05)。这强调了痤疮治疗中合理使用抗生素的重要性。